In this phase, N1 TANs exert cytolytic functions primarily through ROS production and stimulate tumor specific T cells by antigen presentation and pro-inflammatory cytokine production such as IL-1β, IL-6, TNF-α, or IL-17A. The gene discussed is IL17A; the disease is neoplasm.